Have $2,000? 2 Market Crash-Ready Stocks to Buy
You're not alone if you're afraid of a looming market crash. While there's no way to predict what's going to happen with the ongoing bear market, it's definitely quite disturbing to think your portfolio could take a big hit on top of the grinding downward journey we've experienced this year.
However, especially if you have some investable cash on hand, the good news is that there are a few businesses that should retain most of their value during a crash, if one occurs. Specifically, there are a pair of pharmaceutical companies whose roster of in-demand medicines makes their prospects better than most in the face of market turbulence of any kind, so let's analyze each and see why they could be a smart pickup for some downside protection.
Pfizer (NYSE: PFE) is a company that needs no introduction, especially not after its rapid development and commercialization of Comirnaty, its coronavirus vaccine. Besides making medicines like Comirnaty, which management anticipates will pull in $32 billion for 2022, it also has other drugs worth tens of billions of dollars per year, like Paxlovid, an antiviral pill for coronavirus infections. Paxlovid is expected to sell $22 billion this year, and it should push the company's top line to between $98 billion and $102 billion. And as long as SARS-CoV-2 is circulating -- and it will be -- demand for those two products will be significant, though it might be hard to beat this year's haul.
Source Fool.com
